Literature DB >> 2566204

Weight gain associated with psychotropic drugs.

K T Brady1.   

Abstract

The weight increase that is an often reported side effect of psychotropic drug use has implications for health risks as well as medication noncompliance. In this article I review the literature on the association between the use of several classes of psychotropic drugs and weight gain, discuss the possible mechanisms for this effect, and offer some practical approaches for reducing the risk of drug-induced weight gain, including the identification of a group of patients "at risk."

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566204     DOI： 10.1097/00007611-198905000-00017

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  10 in total

Review 1.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.

Authors:  Star Khoza; Jamie C Barner
Journal:  Int J Clin Pharm       Date:  2011-04-13

3.  Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses.

Authors:  K I Melkersson; A L Hulting; A J Rane
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

Review 4.  Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.

Authors:  J M Russell; J A Mackell
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.

Authors:  C Fleischhaker; P Heiser; K Hennighausen; B Herpertz-Dahlmann; K Holtkamp; C Mehler-Wex; R Rauh; H Remschmidt; E Schulz; A Warnke
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

Review 6.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

7.  Metabolic Effects of Antidepressant Treatment.

Authors:  Özlem Olguner Eker; Saliha Özsoy; Baki Eker; Hatice Doğan
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

Review 8.  Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism.

Authors:  K I Melkersson; M-L Dahl; A-L Hulting
Journal:  Psychopharmacology (Berl)       Date:  2004-06-25       Impact factor: 4.530

9.  Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.

Authors:  Christian Fleischhaker; Philip Heiser; Klaus Hennighausen; Beate Herpertz-Dahlmann; Kristian Holtkamp; Claudia Mehler-Wex; Reinhold Rauh; Helmut Remschmidt; Eberhard Schulz; Andreas Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008-09-09       Impact factor: 3.575

Review 10.  Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.

Authors:  Othman Sentissi; Jacques Epelbaum; Jean-Pierre Olié; Marie-France Poirier
Journal:  Schizophr Bull       Date:  2007-12-28       Impact factor: 9.306
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.